| Year |
Citation |
Score |
| 2018 |
Sharma S, Khadimallah I, Corya AW, Ali YO, Rao X, Liu Y, Lu HC. Presymptomatic change in microRNAs modulates Tau pathology. Scientific Reports. 8: 9251. PMID 29915328 DOI: 10.1038/S41598-018-27527-6 |
0.47 |
|
| 2017 |
Ali YO, Bradley G, Lu HC. Corrigendum: Screening with an NMNAT2-MSD platform identifies small molecules that modulate NMNAT2 levels in cortical neurons. Scientific Reports. 7: 46780. PMID 28447617 DOI: 10.1038/Srep46780 |
0.458 |
|
| 2017 |
Ali YO, Bradley G, Lu HC. Screening with an NMNAT2-MSD platform identifies small molecules that modulate NMNAT2 levels in cortical neurons. Scientific Reports. 7: 43846. PMID 28266613 DOI: 10.1038/Srep43846 |
0.538 |
|
| 2017 |
Sharma S, Ali YO, Khadimallah I, Williamson AC, Lu H. [P4-040]: ROLE OF MICRORNAS IN ALZHEIMER'S DISEASE (AD) Alzheimer's & Dementia. 13: P1271-P1272. DOI: 10.1016/J.Jalz.2017.06.1904 |
0.474 |
|
| 2016 |
Ali YO, Allen HM, Yu L, Li-Kroeger D, Bakhshizadehmahmoudi D, Hatcher A, McCabe C, Xu J, Bjorklund N, Taglialatela G, Bennett DA, De Jager PL, Shulman JM, Bellen HJ, Lu HC. NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies. Plos Biology. 14: e1002472. PMID 27254664 DOI: 10.1371/Journal.Pbio.1002472 |
0.555 |
|
| 2016 |
Slivicki RA, Ali YO, Lu HC, Hohmann AG. Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo. Plos One. 11: e0147620. PMID 26808812 DOI: 10.1371/Journal.Pone.0147620 |
0.518 |
|
| 2015 |
Ciupek SM, Cheng J, Ali YO, Lu HC, Ji D. Progressive functional impairments of hippocampal neurons in a tauopathy mouse model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 8118-31. PMID 26019329 DOI: 10.1523/Jneurosci.3130-14.2015 |
0.552 |
|
| 2014 |
Majid T, Ali YO, Venkitaramani DV, Jang MK, Lu HC, Pautler RG. In vivo axonal transport deficits in a mouse model of fronto-temporal dementia. Neuroimage. Clinical. 4: 711-7. PMID 24936422 DOI: 10.1016/J.Nicl.2014.02.005 |
0.511 |
|
| 2013 |
Ali YO, Li-Kroeger D, Bellen HJ, Zhai RG, Lu HC. NMNATs, evolutionarily conserved neuronal maintenance factors. Trends in Neurosciences. 36: 632-40. PMID 23968695 DOI: 10.1016/J.Tins.2013.07.002 |
0.526 |
|
| 2013 |
Zang S, Ali YO, Ruan K, Zhai RG. Nicotinamide mononucleotide adenylyltransferase maintains active zone structure by stabilizing Bruchpilot. Embo Reports. 14: 87-94. PMID 23154466 DOI: 10.1038/Embor.2012.181 |
0.329 |
|
| 2012 |
Ljungberg MC, Ali YO, Zhu J, Wu CS, Oka K, Zhai RG, Lu HC. CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy. Human Molecular Genetics. 21: 251-67. PMID 22027994 DOI: 10.1093/Hmg/Ddr492 |
0.595 |
|
| 2012 |
Ali YO, Ruan K, Zhai RG. NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy. Human Molecular Genetics. 21: 237-50. PMID 21965302 DOI: 10.1093/Hmg/Ddr449 |
0.485 |
|
| 2011 |
Ali YO, McCormack R, Darr A, Zhai RG. Nicotinamide mononucleotide adenylyltransferase is a stress response protein regulated by the heat shock factor/hypoxia-inducible factor 1alpha pathway. The Journal of Biological Chemistry. 286: 19089-99. PMID 21478149 DOI: 10.1074/Jbc.M111.219295 |
0.316 |
|
| 2010 |
Ali YO, Kitay BM, Zhai RG. Dealing with misfolded proteins: examining the neuroprotective role of molecular chaperones in neurodegeneration. Molecules (Basel, Switzerland). 15: 6859-87. PMID 20938400 DOI: 10.3390/Molecules15106859 |
0.33 |
|
| Show low-probability matches. |